BLU-5937

BLU-5937 · Bellus Health Inc. (a GSK company)

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for BLU-5937, covering 2021-08-03 to 2026-07-14. Get the full timeline:

Most recent: Clinical Trial Update: A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough [Phase 3]